PENTAX Medical and Advanced Sterilization Products Unveil Revolutionary Sterilizable Duodenoscope

The Future of Endoscopy: PENTAX Medical Launches the Sterilizable DEC™ Duodenoscope

In the ever-evolving field of medical technology, PENTAX Medical, in collaboration with Advanced Sterilization Products (ASP), has made a significant leap forward with the launch of the Sterilizable DEC™ Duodenoscope. Announced on September 23, 2025, in Montvale, New Jersey, this groundbreaking creation is designed to revolutionize endoscopic procedures across the United States by providing a reusable option equipped with a rapid sterilization process that takes only 68 minutes.

A Response to Industry Challenges

This innovative duodenoscope is a direct response to the longstanding concerns surrounding cross-contamination associated with traditional endoscopic equipment. Unlike single-use models currently available, the Sterilizable DEC™ Duodenoscope emphasizes sustainable practices without compromising the quality of care. It is engineered to provide the stability and control that physicians require, all while enhancing infection prevention measures.

Dr. Kavel Visrodia, a well-respected endoscopist based in New York, highlighted the critical importance of this development: "Despite advances in the control of duodenoscope cross-contamination, the issue remains unresolved in many settings. The capability to sterilize a reusable endoscope marks a notable step forward in patient safety and infection control. This technology allows physicians to continue utilizing familiar scopes while adapting to the sterilization needs dictated by varying patient conditions."

Swift and Safe Sterilization

The incorporation of ASP's STERRAD™ System into the Sterilizable DEC™ design empowers healthcare facilities with efficient workflows that do not sacrifice safety. This built-in sterilization capability permits healthcare providers to customize their processing without jeopardizing infection control measures. As facilities increasingly prioritize both operational efficiency and patient safety, this dual focus is paramount for enhancing care standards.

The product was officially rolled out in the U.S. market starting July 1, 2025, and is anticipated to be pivotal in surgical settings. The ability to swiftly sterilize the duodenoscope ensures that institutions can meet tight schedules and high safety standards.

PENTAX Medical: A Commitment to Excellence

PENTAX Medical, a branch of the esteemed HOYA Group, is committed to elevating patient care standards through advanced medical technology. Their mission focuses on delivering exceptional endoscopic products and services that underscore quality, clinically relevant innovation, and simplicity.

With a strong emphasis on understanding the daily challenges faced by healthcare professionals, PENTAX Medical aims to equip practitioners with the tools necessary for optimal patient outcomes. The launch of the Sterilizable DEC™ Duodenoscope aligns perfectly with their pledge to enhance both patient and provider experiences by equipping them with scientifically validated solutions across all stages of care. This commitment is built upon a foundation of transparent partnerships and a dedication to efficacy and cost-effectiveness.

HOYA Corporation: A Global Leader

Founded in Tokyo in 1941, HOYA Corporation has grown to become a global leader in technology and med-tech solutions. Featuring a diverse array of products, from medical endoscopes to semiconductor components, HOYA is at the forefront of innovation. Employing a workforce of around 38,000 worldwide, the company emphasizes both lifecare and information technology objectives, showcasing its versatility across various sectors.

For additional insights regarding PENTAX Medical and their product innovations, visit their official website at PENTAX Medical. For comprehensive information on HOYA Corporation, their offerings can be explored at HOYA Corporation.